Okay, zero is too much...but I think this stock is a short not a long
Vianet (LON:VNET) is a company I've glanced at in the past but never spent time looking. Today I looked a bit more as its got high recurring revenues, there's a chance of a delayed covid bounce back and it could have both value/recovery and compound growth potential.
My conclusion is to be a bit concerned for it. I feel it may be a company with a good business concept but poor execution and capability. Also, the cash position is weaker than they present and deteriorated much more markedly as a result of covid than their 'resilience' claim.
Some points to back the above:
- Over prior two financial years there was a positive £1.6m impact to earnings from 'deferred consideration release' connected to Oct 2017 Vendeman acquisition - £1.1m fy20 and £0.5m fy19. This is negative as it means that Vendeman has not attained targets (pre covid hit). Mgt defend by saying say that the targets were very stretching.
- £1.2m capitalised developments spend in hy21 released today (£300k higher than hy20...slightly odd given that times are hard during covid and the cynic in me thinks it could be as that's £300k boost to earnings YoY!). This spend has been running at around £2m pa for several years now. That's added back to earnings too....
- ...amortisation has picked up at £0.8m during half year reflecting the prior year increases so the net boost to earning only £0.4m (actually 0.35 fixing rounding)....
- ...that said, at fy20 there was £4.5m net book value of capital development of which £3.2m R&D in progress. Ie this means that the amortisation of that hasn't started. This could be positive in that it does translate into commercial revenues leading to 'good' amortisation in recognition of the investment....but it could be bad and lead to write downs of that (so non cash exceptionals through P&L)...both outcomes look the same on P&L but one implies successful investment and the other not
- A combination of Vendeman release and CEO announcing departure today make me think that there's a high chance recent investment program hasn't been as productive as desired
- In hy21 today they also showed a large £550k drop in PPE investment (obvs covid response) from £680k to £130k. This likely needs to be caught back up with
- CBILS loan of £3.5m explains £3.3m increase in cash, so £0.2m…